Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1115

1.

Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.

Fava M, Rosenbaum JF, Hoog SL, Tepner RG, Kopp JB, Nilsson ME.

J Affect Disord. 2000 Aug;59(2):119-26.

PMID:
10837880
[PubMed - indexed for MEDLINE]
2.

Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia.

Fava M, Hoog SL, Judge RA, Kopp JB, Nilsson ME, Gonzales JS.

J Clin Psychopharmacol. 2002 Apr;22(2):137-47.

PMID:
11910258
[PubMed - indexed for MEDLINE]
3.

Sertraline versus fluoxetine in the treatment of major depression: a combined analysis of five double-blind comparator studies.

Feiger AD, Flament MF, Boyer P, Gillespie JA.

Int Clin Psychopharmacol. 2003 Jul;18(4):203-10.

PMID:
12817154
[PubMed - indexed for MEDLINE]
4.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
[PubMed - indexed for MEDLINE]
5.

Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.

Miner CM, Brown EB, Gonzales JS, Munir R.

J Clin Psychiatry. 2002 Mar;63(3):232-40.

PMID:
11926723
[PubMed - indexed for MEDLINE]
6.

A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients.

Sechter D, Troy S, Paternetti S, Boyer P.

Eur Psychiatry. 1999 Mar;14(1):41-8.

PMID:
10572324
[PubMed - indexed for MEDLINE]
7.

A double-blind multicenter trial comparing sertraline and fluoxetine in outpatients with major depression.

Bennie EH, Mullin JM, Martindale JJ.

J Clin Psychiatry. 1995 Jun;56(6):229-37.

PMID:
7775364
[PubMed - indexed for MEDLINE]
8.

Predictors of an acute antidepressant response to fluoxetine and sertraline.

Flament MF, Lane RM, Zhu R, Ying Z.

Int Clin Psychopharmacol. 1999 Sep;14(5):259-75.

PMID:
10529069
[PubMed - indexed for MEDLINE]
9.

Efficacy of venlafaxine extended release in patients with major depressive disorder and comorbid generalized anxiety disorder.

Silverstone PH, Salinas E.

J Clin Psychiatry. 2001 Jul;62(7):523-9.

PMID:
11488362
[PubMed - indexed for MEDLINE]
10.

Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.

Alpert JE, Franznick DA, Hollander SB, Fava M.

J Clin Psychiatry. 2004 Aug;65(8):1069-75.

PMID:
15323591
[PubMed - indexed for MEDLINE]
11.

Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment.

Fava M, Judge R, Hoog SL, Nilsson ME, Koke SC.

J Clin Psychiatry. 2000 Nov;61(11):863-7.

PMID:
11105740
[PubMed - indexed for MEDLINE]
12.

Fluoxetine treatment of depressed patients with comorbid anxiety disorders.

Sonawalla SB, Farabaugh A, Johnson MW, Morray M, Delgado ML, Pingol MG, Rosenbaum JF, Fava M.

J Psychopharmacol. 2002 Sep;16(3):215-9.

PMID:
12236627
[PubMed - indexed for MEDLINE]
13.

Selective serotonin reuptake inhibitor treatment for generalized anxiety disorder: a double-blind, prospective comparison between paroxetine and sertraline.

Ball SG, Kuhn A, Wall D, Shekhar A, Goddard AW.

J Clin Psychiatry. 2005 Jan;66(1):94-9.

PMID:
15669894
[PubMed - indexed for MEDLINE]
14.

A Canadian multicenter, double-blind study of paroxetine and fluoxetine in major depressive disorder.

Chouinard G, Saxena B, Bélanger MC, Ravindran A, Bakish D, Beauclair L, Morris P, Vasavan Nair NP, Manchanda R, Reesal R, Remick R, O'Neill MC.

J Affect Disord. 1999 Jul;54(1-2):39-48.

PMID:
10403145
[PubMed - indexed for MEDLINE]
15.

Bupropion sustained release versus paroxetine for the treatment of depression in the elderly.

Weihs KL, Settle EC Jr, Batey SR, Houser TL, Donahue RM, Ascher JA.

J Clin Psychiatry. 2000 Mar;61(3):196-202.

PMID:
10817105
[PubMed - indexed for MEDLINE]
16.

Efficacy and response time to sertraline versus fluoxetine in the treatment of unipolar major depressive disorder.

Suri RA, Altshuler LL, Rasgon NL, Calcagno JL, Frye MA, Gitlin MJ, Hwang S, Zuckerbrow-Miller J.

J Clin Psychiatry. 2000 Dec;61(12):942-6.

PMID:
11206600
[PubMed - indexed for MEDLINE]
17.

Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group.

Mehtonen OP, Søgaard J, Roponen P, Behnke K.

J Clin Psychiatry. 2000 Feb;61(2):95-100.

PMID:
10732656
[PubMed - indexed for MEDLINE]
18.

A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression.

Musselman DL, Somerset WI, Guo Y, Manatunga AK, Porter M, Penna S, Lewison B, Goodkin R, Lawson K, Lawson D, Evans DL, Nemeroff CB.

J Clin Psychiatry. 2006 Feb;67(2):288-96.

PMID:
16566626
[PubMed - indexed for MEDLINE]
19.

Efficacy and tolerability of Paroxetine 20 mg daily in the treatment of depression and depression associated anxiety.

Chaudhry HR, Qureshi Z, Tareen IA, Yazdani I.

J Pak Med Assoc. 2002 Nov;52(11):518-25.

PMID:
12585372
[PubMed - indexed for MEDLINE]
20.

The relationship between early changes in the HAMD-17 anxiety/somatization factor items and treatment outcome among depressed outpatients.

Farabaugh A, Mischoulon D, Fava M, Wu SL, Mascarini A, Tossani E, Alpert JE.

Int Clin Psychopharmacol. 2005 Mar;20(2):87-91.

PMID:
15729083
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk